التفاصيل البيبلوغرافية
| العنوان: |
LBA2 Impact of RNA expression signatures and tumour infiltrating lymphocytes (TILs) for pathological complete response (pCR) and survival after 12 week de-escalated neoadjuvant pertuzumab + trastuzumab ± paclitaxel in the WSG-HER2+/HR- ADAPT trial. |
| المؤلفون: |
Graeser, M.1, Gluz, O.2, Biehl, C.3, Ulbrich-Gebauer, D.4, Palatty, J.3, Christgen, M.5, Kuemmel, S.6, Grischke, E-M.7, Augustin, D.8, Braun, M.9, Potenberg, J.10, Wuerstlein, R.11, Eulenburg, C.1, Kates, R.1, Kolberg-Liedtke, C.12, Feuerhake, F.5, Kreipe, H.5, Nitz, U.2, Harbeck, N.13 |
| المصدر: |
Annals of Oncology. 2021 Supplement 2, Vol. 32, pS48-S48. 1p. |
| مصطلحات موضوعية: |
*NEOADJUVANT chemotherapy, *BREAST cancer treatment, *TREATMENT effectiveness |
| قاعدة البيانات: |
Academic Search Index |
Full Text Finder